An open‐label, randomized, 64‐week study repeating 10‐ and 20‐U doses of botulinum toxin type A for treatment of glabellar lines in Japanese subjects

Background  Repeated botulinum toxin type A (BoNTA) treatment typifies clinical practice. The long‐term safety and efficacy should be demonstrated in diverse populations.

[1]  M. Kawashima,et al.  ORIGINAL ARTICLE A Double-Blind, Randomized, Placebo-Controlled, Two-Dose Comparative Study of Botulinum Toxin Type A for Treating , 2022 .

[2]  K. De Boulle.  Botulinum neurotoxin type A in facial aesthetics , 2007, Expert opinion on pharmacotherapy.

[3]  K. Boulle.  Botulinum neurotoxin type A in facial aesthetics. , 2007 .

[4]  N. Lowe.  International Experts Roundtable Proceedings Supplement , 2007 .

[5]  M. Gordon,et al.  Effectiveness of Repeated Treatment with Botulinum Toxin Type A Across Different Conditions , 2006, Southern medical journal.

[6]  J. Carruthers,et al.  Prospective, Double‐Blind, Randomized, Parallel‐Group, Dose‐Ranging Study of Botulinum Toxin Type A in Men with Glabellar Rhytids , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[7]  J. Carruthers,et al.  Dose‐Ranging Study of Botulinum Toxin Type A in the Treatment of Glabellar Rhytids in Females , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[8]  R. P. Clark,et al.  Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. , 2005, Plastic and reconstructive surgery.

[9]  J. Carruthers,et al.  Consensus recommendations on the use of botulinum toxin type a in facial aesthetics. , 2004, Plastic and reconstructive surgery.

[10]  J. Carruthers,et al.  Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Botulinum Toxin Type A for Patients with Glabellar Lines , 2003, Plastic and reconstructive surgery.

[11]  J. Carruthers,et al.  A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. , 2002, Journal of the American Academy of Dermatology.

[12]  M. Brin,et al.  Botulinum toxin for the treatment of hyperfunctional lines of the face. , 1993, Archives of otolaryngology--head & neck surgery.

[13]  T. Flynn.  Update on botulinum toxin. , 2007, Seminars in cutaneous medicine and surgery.

[14]  J. Carruthers,et al.  Treatment of glabellar frown lines with C. botulinum-A exotoxin. , 1992, The Journal of dermatologic surgery and oncology.